MktsMarkets

PTC Therapeutics, Inc.
NASDAQ: PTCTKey statistics
PTCT News
Stories mentioning PTCT from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 272,551 | 164,677 | 211,007 | 178,875 | 1,176,096 | 213,172 | 196,786 | 186,704 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | 100,873 | 133,128 | 100,158 | 112,990 | 108,973 | 124,770 | 161,412 | 132,169 |
| Sales General & Admin | 86,183 | 96,874 | 84,046 | 85,262 | 80,961 | 84,683 | 73,456 | 69,500 |
| Total Operating Expenses | 227,592 | 236,026 | 207,991 | 213,832 | 205,871 | 375,561 | 251,296 | 226,922 |
| Operating Income (Loss) | 44,959 | (71,349) | 3,016 | (34,957) | 970,225 | (162,389) | (54,510) | (40,218) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 1,609 | (12,546) | 6,502 | (5,737) | (6,305) | 8,850 | (1,872) | (2,025) |
| Pretax Income | (2,462) | (139,083) | (23,074) | (71,052) | 929,828 | (94,699) | (97,991) | (85,733) |
| Tax Provision | 347.00 | (4,118) | (38,970) | (6,203) | 63,266 | (28,813) | 8,663 | 13,446 |
| Net Income (Loss) | (2,809) | (134,965) | 15,896 | (64,849) | 866,562 | (65,886) | (106,654) | (99,179) |
| Earnings Per Share (Basic) | (0.03) | (1.70) | 0.20 | (0.83) | 11.09 | (0.86) | (1.39) | (1.29) |
| Earnings Per Share (Diluted) | (0.03) | (1.53) | 0.20 | (0.83) | 10.04 | (0.86) | (1.39) | (1.29) |
| Weighted Average Shares Outstanding (Basic) | 82,521 | 79,534 | 78,471 | 78,151 | 78,116 | 76,845 | 76,926 | 76,725 |
| Weighted Average Shares Outstanding (Diluted) | 82,521 | 88,311 | 87,115 | 78,151 | 86,386 | 76,845 | 76,926 | 76,725 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About PTCT
PTC Therapeutics, Inc. (NASDAQ: PTCT) is a stock listed on the Nasdaq Stock Market under the ticker symbol PTCT. It last traded at $59.38 (Nov 19, 2026, 9:30 AM ET), down 1.4% on the day. That gives PTC Therapeutics a market capitalisation of $5.5B.
Over the past 52 weeks PTCT has traded between $58.80 and $90.87.
Revenue for the quarter ended Mar 31, 2026 was $272.6M; a net loss of $2.8M. Revenue was down 76.8% from $1.2B in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $272.6M | -$2.8M | -1.0% |
| Dec 31, 2025 | $164.7M | -$135.0M | -82.0% |
| Sep 30, 2025 | $211.0M | $15.9M | 7.5% |
| Jun 30, 2025 | $178.9M | -$64.8M | -36.3% |
From PTC Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…